Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

On January 10, 2024, Praxis Precision Medicines Delivered Written Notice To Jefferies To Terminate Sales Agreement, Under Which Company Could Offer, Sell Shares Of Common Stock With Offering Price Of Up To $75M

Author: Charles Gross | January 11, 2024 07:06am

-8-K

Posted In: PRAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist